GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

The United Kingdom's health regulator is investigating weight loss jabs like Ozempic and Mounjaro after linking it to ...

Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Two major metabolic responses to glucagon have previously been demonstrated. 5 Normal subjects receiving 0.5 mg. intravenously show a ... and the departments of Preventive Medicine, Medicine and ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...